Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Interest Coverage Ratio (2016 - 2017)

Historic Interest Coverage Ratio for Corcept Therapeutics (CORT) over the last 5 years, with Q2 2017 value amounting to 130.56.

  • Corcept Therapeutics' Interest Coverage Ratio rose 449734.82% to 130.56 in Q2 2017 from the same period last year, while for Mar 2018 it was 705.2, marking a year-over-year increase of 251369.0%. This contributed to the annual value of 1293.28 for FY2011, which is 1784.09% down from last year.
  • Per Corcept Therapeutics' latest filing, its Interest Coverage Ratio stood at 130.56 for Q2 2017, which was up 449734.82% from 2.84 recorded in Q2 2016.
  • Corcept Therapeutics' Interest Coverage Ratio's 5-year high stood at 130.56 during Q2 2017, with a 5-year trough of 2.84 in Q2 2016.